Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
New, Vintage, and Signed Blotter Art
Contribute $50 or more and get a piece of displayable
blotter art. These look great framed on the wall !
4-HO-MET
Legal Status
by Erowid
U.S. FEDERAL LAW #
Caution :   All legal information should be verified through other sources. [see below]
U.S. FEDERAL LEGAL SUMMARY
4-HO-MET
REGULATED
No
STATUS
Not Approved For
Human Consumption
SCHEDULE
Possible Analog
4-HO-MET is unscheduled in the United States. It is possible that it could be considered an analog (of psilocin and psilocybin), in which case, sales for human consumption or possession with the intent to ingest could be prosecuted under the Federal Analogue Act though we are unaware of any such existing cases (8/12/2011).

U.S. STATE LAW #
If you have information about the legal status of this substance in any U.S. state, please let us know.

INTERNATIONAL LAW #
Sweden #
4-HO-MET was added to Schedule I (slightly different than US Schedule I), making it illegal to possess without a license as of May 2012. Medical Products Agency lists it in their regulation LVFS 2012:6 listed as 4-HO-MET 3-[2-[etyl(metyl)amino]etyl]-1H-indol-4-ol. (thanks h) (last updated Feb 24, 2015)
United Kingdom (U.K., England, Wales, Scotland, Northern Ireland) #
4-HO-MET is considered a controlled substance under the UK's catch-all recreational tryptamine ban. (unconfirmed) (thanks h) (last updated Feb 24, 2015)
If you have information about the legal status of this substance in any other country, please let us know.

CAUTION & DISCLAIMER #
Erowid legal information is a summary of data gathered from site visitors, government documents, websites, and other resources. We are not lawyers and can not guarantee the accuracy of the information provided here. We do our best to keep this information correct and up-to-date, but laws are complex and constantly changing. Laws may also vary from one jurisdiction to another (county, state, country, etc)...this list is not comprehensive.